Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2016
As of Feb 29, 2016
Q2 FY2016
As of Nov 30, 2015
Q1 FY2016
As of Aug 31, 2015
Q4 FY2015
As of May 31, 2015
Q3 FY2015
As of Feb 28, 2015
Q2 FY2015
As of Nov 30, 2014
Q1 FY2015
As of Aug 31, 2014
Q4 FY2014
As of May 31, 2014
Q3 FY2014
As of Feb 28, 2014
Q2 FY2014
As of Nov 30, 2013
Q1 FY2014
As of Aug 31, 2013
Q4 FY2013
As of May 31, 2013
Q3 FY2013
As of Feb 28, 2013
Q2 FY2013
As of Nov 30, 2012
Q3 FY2012
As of Feb 28, 2012
Q2 FY2012
As of Nov 30, 2011
Q1 FY2012
As of Aug 31, 2011
Q4 FY2011
As of Jun 30, 2011
Assets
Assets from discontinued operations (Note 2)
Cash and cash equivalent
Cash and cash equivalents
Restricted Cash
Notes receivable
Other receivables
Other receivables, net
Inventory, net
Advances to suppliers
Investment in Sales-type lease-current
Due from related parties
Deferred tax assets-current
Deferred tax assets
Accounts receivable
Assets from discontinued operations (Note 4)
Total Current Assets
Computer software and equipment
Investment in Sales-type lease
Investment in Sales-type lease-non current
Deposit for equipment purchase
Deferred tax assets-non current
Total other assets
Goodwill
Other receivable
Assets from discontinued operations (Note 4)
Total Assets
Liabilities and Stockholders' Equity
Current Liabilities:
Short term loans
Notes payable
Accounts payable and accrued expenses
Taxes payable
Advances from customers
Deferred revenue-current
Due to related parties
Liabilities from discontinued operations (Note 2)
Accrued debt issuance costs, net
Due to shareholder
Notes payable, net
Other current liabilities
Convertible notes payable, net
Derivative liability
Liabilities from discontinued operations (Note 4)
Total Current Liabilities
LONG TERM LIABILITIES-DEFERRED REVENUE
Liabilities from discontinued operations (Note 4)
Total Liabilities
Stockholders' Equity:
Preferred stock, $0.001 par value, 10,000,000 shares authorized; 9,500,000 and 0 shares designated as Series A at February 29, 2016 (unaudited) and May 31, 2015, respectively
Common stock, $0.001 par value, 150,000,000 shares authorized; 28,921,403 and 34,325,241 shares issued and outstanding at February 29, 2016 (unaudited) and May 31, 2015, respectively
Additional paid-in capital
Statutory Reserves
Accumulated other comprehensive income
Accumulated deficit
Total Stockholders' Equity
Total Liabilities and Stockholders' Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support